Details
Category: Volume 07 Issue 10 October 2019
Hits: 1050

Title: Spectrum of Neuroendocrine Neoplasms – An Institutional Experience at a Tertiary Care Center

Authors: Mukesh Kumar, Mukta Meel, Deepika Hemrajani

 DOI: https://dx.doi.org/10.18535/jmscr/v7i10.32

Abstract

  

Background: Neuroendocrine neoplasms (NENs) are relatively rare and heterogeneous tumor type, comprising ~2% of all malignancies. These tumours occur at various sites in the human body and are considered as one of the close differentials for many tumours. Various benign and malignant tumours undergo neuroendocrine differentiation. Its incidence is slightly increasing due to advanced imaging modalities. 

The aim of the study is to study the spectrum of neuroendocrine tumours from various sites, their clinical presentation, histomorphological features with immunohistochemistry and review of literature.

Materials and Methods: This is a prospective study for a period of 1 year (Nov 2017-Oct 2018). Surgical resection specimens as well as biopsy were included in the study. Out of the total specimens received, 115 cases were of neuroendocrine tumours. Differential diagnosis of small round cell tumours also was considered and a panel of immunohistochemical markers were included to rule out them. 

Results: Out of the 115 cases, 85 cases (73.9%) were benign lesions & 30 cases (26.1%) were malignant lesions. Female preponderance was noted. Peak incidence was seen in 41-60 years of age group.

Conclusion: Neuroendocrine tumours can occur anywhere in the body and it should be considered in one of the differential diagnosis of solid tumours. Diagnosis must be accurately made.

Keywords: Neuroendocrine Neoplasms, Heterogenous, Neuroendocrine Differentiation.

References

  1. Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing But NET: A review of neuroendocrine Tumours and Carcinomas.  Neoplasia. 2017; 19(12): 991- 1002.
  2. Eltawil KM, Gustafsson BI, Kidd M, Modlin IM. Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy. J Clin Gastroenterol. 2010; 44(10):687-695. 
  3. Modlin IM, Oberg K, and Chung DC. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008; 9: 61–72.
  4. Taal BG and Visser O. Epidemiology of neuroendocrine tumours. Neuroendocrinology   2004; 80(1): 3–7.
  5. Klimstra DS, Modlin IR, Adsay NV, Chetty R, Deshpande V, Gonen M, Jensen RT, Kidd MH, Lloyd RV, Moran C, Moss SF, Oberg K, O’Toole D, Rindi G, Robert ME,Suster S, Tang LH, Tzen CY, Washington MK, Wiedenmann B, Yao J. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol. 2010; 34:300–13.
  6. Kloppel G. Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications. Visc Med. 2017; 33:324–30.
  7. Rindi G, Klimstra DS, Abedi- Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, De Krijger RR, Dietel M, El- nagger AK, Fernandez- Cuesta L, Kloppel G, McCluggage WG, Moch H, Ohgaki H, Rakha EA, Reed NS, Rous BA, Sasano H, Scarpa A, Scoazec JY, Travis WD, Tallini G, Trouillas J, Van Krieken JH, Cree IA. A common classification framework for neuroendocrine neoplasms: an Internat-ional Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Modern Pathology 2018; 31:1770–1786. https://doi.org/10.1038/s41379-018-0110-y
  8. Capella C, Heitz PU, Hofler H, Solcia E, Kloppel G. Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Virchows Arch 1995; 425(6):547-560. 
  9. Ozbilim G, Kilicarslan B, Tezer E, Buyukkece A, Ustun M, Karaveli S, Oygur N. Breast carcinoma showing neuroendocrine differentiation characterized with ectopic hormone production (2 case reports). Turk J Med Sci 2000; 30:609-613. 
  10. Nicoletti S, Papi M, Drudi F, Fantini M, Canuti D, Tamburini E, Possenti E, Pasquini E, Brisigotti M, Ravaioli A. Small cell neuroendocrine tumor of the breast in a 40 year-old woman: a case report. Journal of Medical Case Reports 2010; 4:201. 
  11. Feyrter F, Hartmann G. On the carcinoid growth form of the carcinoma mammae, especially the carcinoma solidum (Gelatinosum) mammae. Frankf Z Pathol 1963; 73:24-39. 
  12. Prathima P, Neelaveni N, Swapna G, Anunay J, Ezhilarasi N. Spectrum of neuroendocrine tumours- a tertiary care centre experience. J. Evid. Based Med. Healthc. 2016; 3(92), 5035-5038. DOI: 10.18410/jebmh/2016/1056.
  13. Zuetenhorst JM, Taal BG. Metastatic carcinoid tumors: a clinical review. Oncologist 2005; 10(2): 123-131.

Corresponding Author

Dr Mukta Meel

Assistant Professor, Department of Pathology, SMS Medical College, Jaipur (Rajasthan), India